表紙
市場調査レポート

上室性頻拍症:世界の治験レビュー

Supraventricular Tachycardia Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 315201
出版日 ページ情報 英文 55 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
上室性頻拍症:世界の治験レビュー Supraventricular Tachycardia Global Clinical Trials Review, H2, 2014
出版日: 2014年09月30日 ページ情報: 英文 55 Pages
概要

当レポートでは、上室性頻拍症に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 上室性頻拍症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要国における治験件数

G7諸国での治験件数:心血管系疾患の治験件数に対する上室性頻拍症の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7カ国)での治験件数:心血管系疾患の治験件数に対する上室性頻拍症の治験件数比率

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別治験件数

有望なスポンサー

有望な薬剤

最新の治験情報

治験のプロファイル

  • 代表的な企業の治験概要
    • 小野薬品工業
  • 代表的な大学・研究所における治験の概要
    • Singapore General Hospital
    • Tehran University of Medical Sciences
    • Royal Adelaide Hospital
    • Schneider Children's Medical Center of Israel
    • University of British Columbia
    • Deutsches Herzzentrum Munchen
    • Catholic University of the Sacred Heart
    • University of Ottawa Heart Institute
    • University of California, San Francisco
    • National Heart, Lung, and Blood Institute

5つの代表的な治験のプロファイル

付録

図表一覧

目次

GlobalData's clinical trial report, "Supraventricular Tachycardia Global Clinical Trials Review, H2, 2014" provides data on the Supraventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Supraventricular Tachycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Supraventricular Tachycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Supraventricular Tachycardia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Supraventricular Tachycardia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Supraventricular Tachycardia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Ono Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Ono Pharmaceutical Co., Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • Singapore General Hospital
      • Clinical Trial Overview of Singapore General Hospital
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • Royal Adelaide Hospital
      • Clinical Trial Overview of Royal Adelaide Hospital
      • Schneider Children's Medical Center of Israel
      • Clinical Trial Overview of Schneider Children's Medical Center of Israel
      • University of British Columbia
      • Clinical Trial Overview of University of British Columbia
      • Deutsches Herzzentrum Munchen
      • Clinical Trial Overview of Deutsches Herzzentrum Munchen
      • Catholic University of the Sacred Heart
      • Clinical Trial Overview of Catholic University of the Sacred Heart
      • University of Ottawa Heart Institute
      • Clinical Trial Overview of University of Ottawa Heart Institute
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Supraventricular Tachycardia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Supraventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Supraventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Supraventricular Tachycardia to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Supraventricular Tachycardia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Singapore General Hospital, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Adelaide Hospital, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Schneider Children's Medical Center of Israel, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Deutsches Herzzentrum Munchen, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Catholic University of the Sacred Heart, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*

List of Figures

  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Supraventricular Tachycardia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Supraventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Supraventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Supraventricular Tachycardia to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Supraventricular Tachycardia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Supraventricular Tachycardia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Supraventricular Tachycardia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top